The use of biomarkers in neuroendocrine tumours. - Wikidata - wikimedia - TriplyDB

The use of biomarkers in neuroendocrine tumours.

The use of biomarkers in neuroendocrine tumours.

http://www.wikidata.org/entity/Q38609117

about

A guide to midgut neuroendocrine tumours (NETs) and carcinoid syndrome.

P2860

Q38958626-3A1AF907-663C-498D-8380-E5349D86C5A4

P2860

The use of biomarkers in neuroendocrine tumours.

http://www.wikidata.org/entity/Q38609117

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

The use of biomarkers in neuroendocrine tumours.

@en

type

label

The use of biomarkers in neuroendocrine tumours.

@en

prefLabel

The use of biomarkers in neuroendocrine tumours.

@en

P1433

Q38609117-682F6407-95FC-428E-B73A-61FD28A5E7C7

P1476

Q38609117-B61737D9-E61F-4D7F-B52E-6228E61AB496

P2093

Q38609117-048A5856-7CF2-4E23-8B8C-3B3B2A8CDCA7

Q38609117-5427AB70-A2EA-48BD-B6AD-C1D9AC82FAE3

P2860

Q38609117-0503F066-50FD-4F14-A438-B6D9A2E962F4

Q38609117-11E772BE-05E4-495E-80ED-D08A0D2A5C14

Q38609117-1B3DC843-F267-444B-AD54-932B2D74905C

Q38609117-1D404654-B8AA-45C6-ABD4-461796CF744A

Q38609117-1E4E8092-7742-4A99-A4EB-33BF721057BC

Q38609117-29416AD2-2B21-4722-9F3C-5BF6E531ED84

Q38609117-30097202-9C12-4406-98C4-BB446266126F

Q38609117-376B9584-DCDB-4DE7-B2BF-D2D2FA20EE64

Q38609117-3998471F-3B48-4D64-9BC3-6FB45B359C2F

Q38609117-45102555-58AD-4051-999F-15E00946C0E7

P304

Q38609117-6A1EFC0D-BE36-4764-89F4-D705586BDFC0

P31

Q38609117-11823AFB-00C0-4174-B815-BE0F1535BDF8

P356

Q38609117-99E70EE2-857F-4D10-8DD8-5255915F4C48

P433

Q38609117-AB6C02DB-7B13-470A-8BBB-050A10B72ACF

P478

Q38609117-84BD4036-B9A7-4406-BC41-62E9C299A1F1

P577

Q38609117-456268C4-33E6-43AA-88BA-D9EFEF2B9B7C

P698

Q38609117-44A0F5C3-DDB2-41C7-9190-2DD47B39A75B

P932

Q38609117-F3BA2FF9-40D5-44BA-843F-20B37AC11EBE

P356

FLGASTRO-2012-100272

P1433

Frontline gastroenterology

P1476

The use of biomarkers in neuroendocrine tumours.

@en

P2093

Martyn E Caplin

http://www.w3.org/2001/XMLSchema#string

Mohid Shakil Khan

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Pancreatic endocrine tumors

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract.

P304

175-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/FLGASTRO-2012-100272

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28839724

http://www.w3.org/2001/XMLSchema#string

P932

5369797

http://www.w3.org/2001/XMLSchema#string